Marvel Biosciences Corp. (TSXV:MRVL)
0.1150
0.00 (0.00%)
Nov 20, 2026, 9:43 AM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 8.49 million as of November 20, 2026. It is the 43,814th most valuable company in the world and the 1,592nd biggest in Canada. Its market cap has decreased by 18.72% in one year.
Market Cap
8.49M
Enterprise Value
9.45M
Revenue
n/a
Global Rank
Country Rank
#1,592 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 8.49M, a decrease of -33.22%. That is a compound annual growth rate of -7.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 8.49M | 8.38% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 14.81M |
| Rapid Dose Therapeutics | 13.09M |
| Onco-Innovations | 12.81M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |
| COSCIENS Biopharma | 8.58M |
| Hemostemix | 7.40M |
| Glow Lifetech | 6.74M |